Boston, MA, United States of America

Hyuk-Soo Seo

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyuk-Soo Seo. Retrieved from https://idiyas.com/inventor/hyuk-soo-seo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hyuk-Soo Seo: Innovator in Cancer Treatment

Introduction

Hyuk-Soo Seo is a prominent inventor based in Boston, MA, known for his significant contributions to cancer research. He has developed innovative solutions aimed at treating multiple myeloma, a type of blood cancer. His work focuses on the development of USP7 inhibitors, which have the potential to revolutionize cancer treatment.

Latest Patents

Hyuk-Soo Seo holds a patent for USP7 inhibitors for treating multiple myeloma. This patent outlines the use of inhibitors of USP7 that are useful in the treatment of cancers and other USP7 mediated diseases. The patent includes a specific formula where various components are described in detail, showcasing the complexity and potential of his invention.

Career Highlights

Hyuk-Soo Seo is affiliated with the Dana-Farber Cancer Institute, a leading organization in cancer research and treatment. His work at this prestigious institution has allowed him to focus on groundbreaking research that aims to improve patient outcomes in cancer therapy.

Collaborations

Some of his notable coworkers include Sara Jean Buhrlage and Kenneth Carl Anderson. Their collaboration in research and development has contributed to advancing the understanding and treatment of cancer.

Conclusion

Hyuk-Soo Seo's innovative work in developing USP7 inhibitors represents a significant advancement in the fight against multiple myeloma. His contributions to cancer research continue to inspire and pave the way for future breakthroughs in treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…